PLoS ONE (Jan 2021)
Correction: Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0237030.].